Balance Sheet
Cash Flow Statement
Capital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesChange in ReceivablesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Exchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesLong-Term Debt IssuancesNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

MoonLake Immunotherapeutics (MLTX) Capital Expenditures (2021 - 2025)

MoonLake Immunotherapeutics' Capital Expenditures history spans 5 years, with the latest figure at $35000.0 for Q1 2025.

  • Quarterly Capital Expenditures fell 83.49% to $35000.0 in Q1 2025 from the year-ago period, while the trailing twelve-month figure was $35000.0 through Dec 2025, down 93.27% year-over-year, with the annual reading at $35000.0 for FY2025, 93.27% down from the prior year.
  • Capital Expenditures came in at $35000.0 for Q1 2025, down from $176000.0 in the prior quarter.
  • In the past five years, Capital Expenditures ranged from a high of $284000.0 in Q4 2023 to a low of -$2.0 in Q2 2022.
  • The 5-year median for Capital Expenditures is $42855.0 (2021), against an average of $91736.8.
  • Year-over-year, Capital Expenditures tumbled 100.0% in 2022 and then soared 28399900.0% in 2023.
  • MoonLake Immunotherapeutics' Capital Expenditures stood at $50710.0 in 2021, then crashed by 100.0% to $1.0 in 2022, then skyrocketed by 28399900.0% to $284000.0 in 2023, then plummeted by 38.03% to $176000.0 in 2024, then crashed by 80.11% to $35000.0 in 2025.
  • Per Business Quant, the three most recent readings for MLTX's Capital Expenditures are $35000.0 (Q1 2025), $176000.0 (Q4 2024), and $132000.0 (Q3 2024).